V

Vimian Group AB
STO:VIMIAN

Watchlist Manager
Vimian Group AB
STO:VIMIAN
Watchlist
Price: 39.8 SEK 0.89% Market Closed
Market Cap: 20.6B SEK
Have any thoughts about
Vimian Group AB?
Write Note
Section:
 

Relative Value

The Relative Value of one VIMIAN stock under the Base Case scenario is 57.62 SEK. Compared to the current market price of 39.8 SEK, Vimian Group AB is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VIMIAN Relative Value
Base Case
57.62 SEK
Undervaluation 31%
Relative Value
Price
V
Worst Case
Base Case
Best Case

Valuation Multiples

5.1
P/S
P/S
Price to Sales
5.1
vs History
41
vs Industry
28
Median 3Y
4.5
Median 5Y
5.1
Industry
2.3
Forward
4.9
More Details
7 058.8
P/E
P/E
Price to Earnings
7 058.8
vs History
4
vs Industry
2
Median 3Y
117.9
Median 5Y
85.8
Industry
23
Forward
42.6
More Details
35.5
P/OCF
P/OCF
Price to OCF
35.5
vs History
60
vs Industry
Median 3Y
41.2
Median 5Y
43
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
11
Median 3Y
10.7
Median 5Y
11.4
Industry
20
More Details
2.7
P/B
P/B
Price to Book Value
2.7
vs History
46
vs Industry
29
Median 3Y
2.7
Median 5Y
2.7
Industry
2.2
More Details
5.7
EV/S
EV/S
Enterprise Value to Sales
5.7
vs History
46
vs Industry
22
Median 3Y
5
Median 5Y
5.7
Industry
2.4
Forward
5.4
More Details
12.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.2
vs History
34
vs Industry
18
Median 3Y
9.6
Median 5Y
10.2
Industry
5
More Details
51.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
51.2
vs History
34
vs Industry
5
Median 3Y
43
Median 5Y
46.2
Industry
12.9
Forward
19.3
More Details
51.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
51.2
vs History
37
vs Industry
7
Median 3Y
43
Median 5Y
49.3
Industry
17.4
Forward
28.9
More Details
39.6
EV/OCF
EV/OCF
Enterprise Value to OCF
39.6
vs History
62
vs Industry
Median 3Y
45.3
Median 5Y
48.1
Industry
14
More Details
56.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
56.4
vs History
55
vs Industry
Median 3Y
60.8
Median 5Y
64.6
Industry
18.2
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
39
vs Industry
38
Median 3Y
1.8
Median 5Y
1.8
Industry
1.9
More Details

Multiples Across Competitors

VIMIAN Competitors Multiples
Vimian Group AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Vimian Group AB
STO:VIMIAN
20.8B SEK 5.1 7 058.8 51.2 51.2
JP
Hoya Corp
TSE:7741
7T JPY 8.6 35.9 23.7 28.5
CH
Alcon AG
SIX:ALC
38.2B CHF 4.3 36.2 17.8 34.4
DK
Coloplast A/S
CSE:COLO B
177.1B DKK 6.6 35.1 22.6 26.6
US
Align Technology Inc
NASDAQ:ALGN
16.3B USD 4.1 36.8 18.6 22.4
KR
HLB Inc
KOSDAQ:028300
10.3T KRW 198.6 -55.5 -85.5 -80.6
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
51B CNY 11.5 27.6 23.9 23.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.7B USD 4.5 15.8 10.9 12.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.3 -17.1 16.6 55.6
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.6 37.1 264.5 462
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.6B USD 4.2 46.5 23.2 38.1
P/E Multiple
Earnings Growth PEG
SE
V
Vimian Group AB
STO:VIMIAN
Average P/E: 814.4
7 058.8
96%
73.5
JP
Hoya Corp
TSE:7741
35.9
15%
2.4
CH
Alcon AG
SIX:ALC
36.2
27%
1.3
DK
Coloplast A/S
CSE:COLO B
35.1
15%
2.3
US
Align Technology Inc
NASDAQ:ALGN
36.8
26%
1.4
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -55.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27.6
24%
1.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
15.8
19%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.1 N/A N/A
UK
ConvaTec Group PLC
LSE:CTEC
37.1
46%
0.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
46.5
37%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
V
Vimian Group AB
STO:VIMIAN
Average EV/EBITDA: 47.3
51.2
23%
2.2
JP
Hoya Corp
TSE:7741
23.7
15%
1.6
CH
Alcon AG
SIX:ALC
17.8
10%
1.8
DK
Coloplast A/S
CSE:COLO B
22.6
11%
2.1
US
Align Technology Inc
NASDAQ:ALGN
18.6
15%
1.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -85.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.9
27%
0.9
US
Lantheus Holdings Inc
NASDAQ:LNTH
10.9
11%
1
CA
Bausch + Lomb Corp
NYSE:BLCO
16.6
22%
0.8
UK
ConvaTec Group PLC
LSE:CTEC
264.5
12%
22
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.2
22%
1.1

See Also

Summary
VIMIAN intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIMIAN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIMIAN stock valuation using valuation multiples.
Wall Street Estimates
VIMIAN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIMIAN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 215,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.